These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 31980606)
1. Single AAV-mediated mutation replacement genome editing in limited number of photoreceptors restores vision in mice. Nishiguchi KM; Fujita K; Miya F; Katayama S; Nakazawa T Nat Commun; 2020 Jan; 11(1):482. PubMed ID: 31980606 [TBL] [Abstract][Full Text] [Related]
2. Retained Plasticity and Substantial Recovery of Rod-Mediated Visual Acuity at the Visual Cortex in Blind Adult Mice with Retinal Dystrophy. Nishiguchi KM; Fujita K; Tokashiki N; Komamura H; Takemoto-Kimura S; Okuno H; Bito H; Nakazawa T Mol Ther; 2018 Oct; 26(10):2397-2406. PubMed ID: 30064895 [TBL] [Abstract][Full Text] [Related]
3. In vivo genome editing as a potential treatment strategy for inherited retinal dystrophies. Yanik M; Müller B; Song F; Gall J; Wagner F; Wende W; Lorenz B; Stieger K Prog Retin Eye Res; 2017 Jan; 56():1-18. PubMed ID: 27623223 [TBL] [Abstract][Full Text] [Related]
4. In Situ Gene Therapy via AAV-CRISPR-Cas9-Mediated Targeted Gene Regulation. Moreno AM; Fu X; Zhu J; Katrekar D; Shih YV; Marlett J; Cabotaje J; Tat J; Naughton J; Lisowski L; Varghese S; Zhang K; Mali P Mol Ther; 2018 Jul; 26(7):1818-1827. PubMed ID: 29754775 [TBL] [Abstract][Full Text] [Related]
5. High levels of AAV vector integration into CRISPR-induced DNA breaks. Hanlon KS; Kleinstiver BP; Garcia SP; Zaborowski MP; Volak A; Spirig SE; Muller A; Sousa AA; Tsai SQ; Bengtsson NE; Lööv C; Ingelsson M; Chamberlain JS; Corey DP; Aryee MJ; Joung JK; Breakefield XO; Maguire CA; György B Nat Commun; 2019 Sep; 10(1):4439. PubMed ID: 31570731 [TBL] [Abstract][Full Text] [Related]
6. Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation-Associated Inherited Retinal Dystrophy: Results of Phase 1 and 3 Trials. Maguire AM; Russell S; Wellman JA; Chung DC; Yu ZF; Tillman A; Wittes J; Pappas J; Elci O; Marshall KA; McCague S; Reichert H; Davis M; Simonelli F; Leroy BP; Wright JF; High KA; Bennett J Ophthalmology; 2019 Sep; 126(9):1273-1285. PubMed ID: 31443789 [TBL] [Abstract][Full Text] [Related]
9. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure. Soriano V AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352 [TBL] [Abstract][Full Text] [Related]
10. In vivo genome editing rescues photoreceptor degeneration via a Cas9/RecA-mediated homology-directed repair pathway. Cai Y; Cheng T; Yao Y; Li X; Ma Y; Li L; Zhao H; Bao J; Zhang M; Qiu Z; Xue T Sci Adv; 2019 Apr; 5(4):eaav3335. PubMed ID: 31001583 [TBL] [Abstract][Full Text] [Related]
13. Methods for In Vivo CRISPR/Cas Editing of the Adult Murine Retina. Hung SS; Li F; Wang JH; King AE; Bui BV; Liu GS; Hewitt AW Methods Mol Biol; 2018; 1715():113-133. PubMed ID: 29188510 [TBL] [Abstract][Full Text] [Related]
14. Application of CRISPR Tools for Variant Interpretation and Disease Modeling in Inherited Retinal Dystrophies. Fuster-García C; García-Bohórquez B; Rodríguez-Muñoz A; Millán JM; García-García G Genes (Basel); 2020 Apr; 11(5):. PubMed ID: 32349249 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic Applications of CRISPR/Cas for Duchenne Muscular Dystrophy. Wong TWY; Cohn RD Curr Gene Ther; 2017; 17(4):301-308. PubMed ID: 29173172 [TBL] [Abstract][Full Text] [Related]
16. Nrl knockdown by AAV-delivered CRISPR/Cas9 prevents retinal degeneration in mice. Yu W; Mookherjee S; Chaitankar V; Hiriyanna S; Kim JW; Brooks M; Ataeijannati Y; Sun X; Dong L; Li T; Swaroop A; Wu Z Nat Commun; 2017 Mar; 8():14716. PubMed ID: 28291770 [TBL] [Abstract][Full Text] [Related]
17. Genome Editing as a Treatment for the Most Prevalent Causative Genes of Autosomal Dominant Retinitis Pigmentosa. Diakatou M; Manes G; Bocquet B; Meunier I; Kalatzis V Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31126147 [No Abstract] [Full Text] [Related]
18. CRISPR-Mediated Integration of Large Gene Cassettes Using AAV Donor Vectors. Bak RO; Porteus MH Cell Rep; 2017 Jul; 20(3):750-756. PubMed ID: 28723575 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic homology-independent targeted integration in retina and liver. Tornabene P; Ferla R; Llado-Santaeularia M; Centrulo M; Dell'Anno M; Esposito F; Marrocco E; Pone E; Minopoli R; Iodice C; Nusco E; Rossi S; Lyubenova H; Manfredi A; Di Filippo L; Iuliano A; Torella A; Piluso G; Musacchia F; Surace EM; Cacchiarelli D; Nigro V; Auricchio A Nat Commun; 2022 Apr; 13(1):1963. PubMed ID: 35414130 [TBL] [Abstract][Full Text] [Related]
20. New Editing Tools for Gene Therapy in Inherited Retinal Dystrophies. Pulman J; Sahel JA; Dalkara D CRISPR J; 2022 Jun; 5(3):377-388. PubMed ID: 35506982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]